Menu

去纤苷2023价格和购买途径?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

The reference price of a box of Jazz Pharmaceuticals (JAZZ) defibrotide (valid until 2024), an Irish biopharmaceutical company, is about $21,505.

However, due to the impact of foreign exchange rate fluctuations, drug prices are not static. Patients who want to know the specific prices can consult the medical companion travel service.

Since defibrotide is not currently on the market in China, patients cannot purchase it in large domestic chain pharmacies and hospital pharmacies.

Patients can choose defibrotide that is marketed overseas and can be purchased through the following channels:

1. Purchase by yourself. Patients can choose to buy medicines overseas by themselves. However, this trip is long and expensive, so it is not recommended. Patients should choose carefully.

2. Drugs can be obtained through professional overseas medical service agencies, such as Medical Companion Travel. This method is cost-effective, convenient and fast. Through overseas direct mail, patients can receive drugs at home and the quality of the drugs can be guaranteed.

It should be noted that it is recommended that patients obtain drugs through formal and legal means, and it is not recommended to purchase them through purchasing agents and other methods to avoid buying fake and shoddy drugs, which will not only have a negative impact on the condition, but may even affect their health.

Defibrotide is approved in the European Union for the treatment of severe hepatic veno-occlusive disease (VOD), also known as sinusoidal veno-occlusive syndrome, during hematopoietic stem cell transplantation (HSCT) in adults, adolescents, children and infants over 1 month of age. Defibrotide is also available in the United States under an expanded access agreement. Defibrinoside is thought to protect endothelial cells and restore the thrombolytic-fibrinolytic balance of VOD.

In a multicenter phase III trial, patients with severe hepatic VOD and multiorgan failure after HSCT who received defibrotide at 6.25 mg/kg intravenously every 6 hours had significantly higher rates of complete remission (the primary endpoint) by 100 days and significantly lower 100-day mortality compared with historical controls.

To sum up, the therapeutic effect of defibrotide drugs is significant. Patients in need can consult the medical companion travel service for detailed drug purchase procedures.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。